Device Trial Radar · NCT05143541
Use of a New Stapling Device in General Thoracic Surgery
Last checked: Nov 20, 2026Latest source record: Dec 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
Mar 1, 2021
Primary completion
Sep 30, 2021
Study completion Sep 30, 2021
Sponsor
- Lead sponsor
- Lexington Medical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 3, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study was to test the safety and efficacy of this stapler in our general thoracic surgery practice.
Conditions
- Thoracic Cancer
Interventions
AEON EndostaplerDevice
Surgery with AEON Endostapler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Product MalfunctionTime frame: Within surgery, up to 8 hours
- Number of Participants With Intraoperative Staple Line BleedingTime frame: Within surgery, up to 8 hours
- Number of Participants With Reported Device-related Adverse EventsTime frame: Within 30-day post-operative period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.